摘要
目的针对残胃出血患者采用奥美拉唑与凝血酶协同治疗的临床价值进行分析。方法在本院于2016年1月至2017年1月内接收的残胃大出血患者中任选86例,任选其中43例,参照常规方式使用奥美拉唑治疗,视为对照组。剩余43例患者则需要在常规治疗的基础上,辅以凝血酶治疗,作为观察组。针对疗效间差异进行对比。结果在整体治疗效率上,观察组总有效率为90.03%(40/43),远高于对照组81.39%(35/43),P<0.05差异具备统计学意义。且观察组在生活质量评分上同样优于对照组,P<0.05差异具备统计学意义。结论针对残胃大出血患者采用奥美拉唑与凝血酶协同进行治疗,综合疗效较高,且能对患者生活质量进行改善。
Objective for the residual stomach bleeding patients with omeprazole and thrombin analysis carried out in cooperation with the clinical value of treatment. Methods in our hospital from January 2016 to January 2017 months of receiving the residual stomach bleeding from 86 cases of patients,choose which 43 cases,consult conventionally treated with omeprazole,as control group.Remaining 43 patients need on the basis of conventional treatment,supplemented by thrombin treatment,as a group. In view of the difference between curative effect were compared. Results In the overall treatment efficiency,observation group total effective rate was90. 03%( 40/43),far higher than the control group 81. 39%( 35/43),P< 0. 05,differences have statistical significance. And observation group on the quality of life score also better than the control group, P < 0. 05, differences have statistical significance. Conclusion for patients with residual stomach bleeding USES omeprazole and thrombin collaborative treatment,comprehensive curative effect is higher,and to improve patient quality of life.
关键词
凝血酶
奥美拉唑
残胃出血
临床疗效
thrombin
Omeprazole
The residual stomach bleeding
Clinical curative effect
